Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Robert F. Kennedy Jr. sounded concern on the GRAS process and claimed GLP-1s are “miracle drugs” but fell short on the drugs ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

The international formula was designed to deliver all the benefits of the US formula while meeting regulatory requirements ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Recently, there has been a lot of buzz around GLP-1 weight loss injections. Talk of Ozempic or Wegovy has been hard to miss.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...